{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-5816", "FDA", "Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications", "Nonrulemaking", "2026-06-03T14:17:35Z", "0b000064b92e47d1", null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-5816"], "units": {}, "query_ms": 0.2717999741435051, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}